Your browser does not support the NLM PubReader view.
Go to this page to see a list of supported browsers
or return to the
regular view.

Page 0 of 0

NCBI Bookshelf

Home Browse All Titles Share on Facebook Share on Twitter

Table of Content

WHO Guidelines Approved by the Guidelines Review Committee Title Information Table of Contents Page

Settings

Switch to classic view PDF (1.3M)Print View

Help

Help Send us feedback About PubReader

✘

Guidelines for Diagnosing and Managing Disseminated Histoplasmosis among People Living with HIV

ACKNOWLEDGMENTS
ABBREVIATIONS AND ACRONYMS
1. EXECUTIVE SUMMARY
2. BACKGROUND
3. KEY RECOMMENDATIONS, RATIONALE, AND EVIDENCE SUMMARY
4. IMPLEMENTATION CONSIDERATIONS
ANNEX 1. METHODS FOR DEVELOPING THE GUIDELINES
ANNEX 2. SUMMARY OF JUDGMENTS ON POPULATION, INTERVENTION, COMPARISON, AND OUTCOME (PICO) QUESTIONS
ANNEX 3. SYSTEMATIC REVIEW PICO 1: PERFORMANCE OF DIAGNOSTIC ASSAYS
ANNEX 4. DIAGNOSTIC TESTS FOR HISTOPLASMOSIS
ANNEX 5. SYSTEMATIC REVIEW PICO 2: HISTOPLASMOSIS TREATMENT
ANNEX 6. SYSTEMATIC REVIEW PICO 3: HISTOPLASMOSIS AND TB COINFECTION
ANNEX 7. DRUG–DRUG INTERACTIONS: RIFAMYCINS OR ANTIFUNGAL DRUGS VERSUS ANTIRETROVIRAL DRUGS
REFERENCES